116 related articles for article (PubMed ID: 6468500)
1. Dopamine agonistic potency of two novel prolactin release-inhibiting ergolines.
Markó M
Eur J Pharmacol; 1984 Jun; 101(3-4):263-6. PubMed ID: 6468500
[TBL] [Abstract][Full Text] [Related]
2. Two novel prolactin release-inhibiting 8 alpha-amino-ergolines.
Flückiger E; Briner U; Bürki HR; Marbach P; Wagner HR; Doepfner W
Experientia; 1979 Dec; 35(12):1677-8. PubMed ID: 520501
[TBL] [Abstract][Full Text] [Related]
3. Effect of ergoline derivative VUFB-6638 on the adenohypophysial prolactin concentration in rats.
Krejcí P; Ausková M; Rezábek K; Bílek J; Semonský M
Endocrinol Exp; 1975 Jan; 9(1):68-72. PubMed ID: 6259
[TBL] [Abstract][Full Text] [Related]
4. Effect of mesulergine on prolactin secretion and dopamine D2 receptors-adaptive changes in diethylstilbestrol-induced hyperplasia of the rat anterior pituitary.
Pisarek H; Stepien H; Pawlikowski M
Endocr Regul; 1992 Mar; 26(1):17-22. PubMed ID: 1421203
[TBL] [Abstract][Full Text] [Related]
5. Suppression of prolactin release and mRNA accumulation by two novel dopamine agonist agents.
Davis JR; Vidal ME; Wilson EM; Sheppard MC
Acta Endocrinol (Copenh); 1989 May; 120(5):672-6. PubMed ID: 2567101
[TBL] [Abstract][Full Text] [Related]
6. Effect of ergovaline, loline, and dopamine antagonists on rat pituitary cell prolactin release in vitro.
Strickland JR; Cross DL; Birrenkott GP; Grimes LW
Am J Vet Res; 1994 May; 55(5):716-21. PubMed ID: 8067623
[TBL] [Abstract][Full Text] [Related]
7. The intrinsic activities of the partial dopamine receptor agonists (-)-3-PPP and TDHL on pituitary dopamine receptors are lower in female than in male rats.
Carlsson M; Carlsson A; Eriksson E
Eur J Pharmacol; 1987 Oct; 142(1):39-43. PubMed ID: 3691635
[TBL] [Abstract][Full Text] [Related]
8. Ergoline congeners as potential inhibitors of prolactin release. 2.
Rusterholz DB; Barfknecht CF; Clemens JA
J Med Chem; 1976 Jan; 19(1):99-102. PubMed ID: 1246056
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of prolactin secretion by lergotrile mesylate: mechanism of action.
Clemens JA; Smalstig EB; Shaar CJ
Acta Endocrinol (Copenh); 1975 Jun; 79(2):230-7. PubMed ID: 166535
[TBL] [Abstract][Full Text] [Related]
10. Novel 8 alpha-ergolines with inhibitory and stimulatory effects on prolactin secretion in rats.
Wachtel H; Dorow R; Sauer G
Life Sci; 1984 Oct; 35(18):1859-67. PubMed ID: 6492995
[TBL] [Abstract][Full Text] [Related]
11. Changes in the concentration of adenohypophyseal prolactin and morphological manifestations in the adenohypophysis of lactating rats after administration of D-6-methyl-8-[beta-isopropylaminoethyl] ergoline-I.
Krejcí P; Marhan O; Ausková M; Rezábek K; Semonský M
Experientia; 1976 Oct; 32(10):1308-9. PubMed ID: 987925
[TBL] [Abstract][Full Text] [Related]
12. Lisuride, a dopamine agonist, inhibits DNA synthesis in the pituitary gland.
Burdman JA; Calabrese MT; Harcus CT; MacLeod RM
Neuroendocrinology; 1982 Oct; 35(4):282-6. PubMed ID: 7145022
[TBL] [Abstract][Full Text] [Related]
13. Effects of fenoldopam on alpha-methyl-p-tyrosine-stimulated prolactin secretion in conscious rats.
Schoors DF; Dupont AG
Eur J Pharmacol; 1989 Nov; 173(1):109-12. PubMed ID: 2575038
[TBL] [Abstract][Full Text] [Related]
14. Alpha 2-agonist activity of the dopamine DA2-agonist LY171555.
Cohen ML; Shaar CJ; Colbert WE
J Cardiovasc Pharmacol; 1984; 6(6):1245-8. PubMed ID: 6084786
[TBL] [Abstract][Full Text] [Related]
15. Metergoline and cyproheptadine suppress prolactin release by a non-5-hydroxytryptaminergic, non-dopaminergic mechanism.
Besser GM; Delitala G; Grossman A; Yeo T
Br J Pharmacol; 1980 Sep; 70(1):5-7. PubMed ID: 7426830
[TBL] [Abstract][Full Text] [Related]
16. Extensive ultrastructural changes in rat mammotrophs following administration of the dopamine agonist ergocristine-reflecting inhibition of prolactin release.
Reifel CW; Shin SH; Leather RA
Cell Tissue Res; 1983; 232(2):249-56. PubMed ID: 6688378
[TBL] [Abstract][Full Text] [Related]
17. Metergoline and other peripheral serotonin antagonists inhibit prolactin secretion through mechanisms unrelated to serotonin.
Lamberts SW; MacLeod RM
Proc Soc Exp Biol Med; 1979 Oct; 162(1):75-9. PubMed ID: 504241
[No Abstract] [Full Text] [Related]
18. Stimulation of prolactin release by the bicarbonate ion.
Lamberts SW; MacLeod RM
Proc Soc Exp Biol Med; 1979 Sep; 161(4):495-7. PubMed ID: 582626
[No Abstract] [Full Text] [Related]
19. Pharmacological effects of BAM-1120, a novel ergoline derivative, on central dopaminergic functions in rats.
Ichihara K; Kamei H; Okumura K; Mizukoshi K; Nagasaka M
Methods Find Exp Clin Pharmacol; 1998 Sep; 20(7):561-6. PubMed ID: 9819799
[TBL] [Abstract][Full Text] [Related]
20. Inhibition of prolactin by ergoline congeners.
Barfknecht CF; Rusterholz DB
J Med Chem; 1974 Mar; 17(3):308-12. PubMed ID: 4811226
[No Abstract] [Full Text] [Related]
[Next] [New Search]
